By Ross Pope, COO & CFO at Prescribery There’s a pre-existing conflict between marketing professionals and the telemedicine industry, and it comes down to measuring conversion rates. Market strategies often…
Ross PopeJune 22, 2021
The Ambiguity of Conversion Rates in Telemedicine
By Ross Pope, COO & CFO at Prescribery There’s a pre-existing conflict between marketing professionals and the telemedicine industry, and…
Read More
By Ross Pope, COO & CFO at Prescribery Patient onboarding is the first critical step in a series of important healthcare access stages across all medical service providers. Prescribery prioritizes…
Ross PopeJune 7, 2021
By Ross Pope, COO & CFO at Prescribery The Covid-19 Pandemic has left an indelible mark on the medical field, and although the tragedies associated with the global health crisis…
Ross PopeMay 10, 2021
By Ross Pope, COO & CFO at Prescribery Earning consumer trust in telemedicine can be challenging. Although CDC data demonstrates that 85% of people over the age of 60 need…
Ross PopeApril 12, 2021
Prescribery recently announced its partnership with KnippeRx to provide Vyleesi, a prescription medication developed by Palatin Technologies, Inc. to treat premenopausal women with hypoactive sexual desire disorder (HSDD). Approved by…
Ross PopeMarch 22, 2021
By Ross Pope, Chief Financial Officer at Prescribery The Health Insurance Portability and Accountability Act (HIPAA) challenges organizations to handle patient and health care data with great care. HIPAA’s purpose…
Ross PopeMarch 16, 2021
